ZBIO
Zenas BioPharma, Inc.
$28.24
-1.17 (-3.98%)
At close · Jul 16
Going-concern doubt
— cleared May 13, 2026
The latest filing states the doubt was alleviated.
“During the first quarter of 2026, the Company alleviated the uncertainty associated with its ability to continue as a going concern through the execution of its senior secured term loan, the issuance of convertible senior notes and the concurrent equity offering”View the 10-Q filed May 13, 2026
Market Cap
$1.78B
Shares
63,133,377
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.